Hila Pharma Overview
Hila Pharma is developing products for molecular imaging that will allow precise diagnoses and improved therapy planning. Its main profits come from the field of nuclear medicine, for which the company trades a broad range of products, aimed at both diagnostic and therapeutic purposes. Hila Pharma is capable of supplying any type of the SPECT range of diagnostic products, PET diagnostic products, MRI contrast agents, and several nuclear therapeutic materials, such as LU-177.
Latest News
growth-positive
Israeli innovation claims to kill over 99% of airborne viruses
Israeli startup ProtectAir has developed an air-purifier that can neutralize over 99% of airborne viruses and bacteria. The device, which releases chlorine dioxide into the air at a low concentration, has been found effective against COVID-19. It can help destroy aerosols carrying the virus and prevent its spread through tiny particles suspended in the air. ProtectAir has received regulatory approvals and has started closing global distribution agreements. The company aims to provide a solution for retirement homes, offices, trains, buses, and other workspaces to create a safer public environment. The device has the potential for long-term use beyond the COVID-19 pandemic.
CustomersPartners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | mcshadowblade.com |
Locations
HaGefen Street 26, Nizan, Israel
Photos & Videos
4 item(s)
